These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3954785

  • 1. Defective bile acid transport in an animal model of defective debrisoquine hydroxylation.
    Reichen J, Krähenbühl S, Küpfer A, Sägesser H, Karlaganis G.
    Biochem Pharmacol; 1986 Mar 01; 35(5):753-9. PubMed ID: 3954785
    [Abstract] [Full Text] [Related]

  • 2. Hydroxylation of debrisoquine using perfused liver isolated from Sprague Dawley and DA rats: comparison with in-vivo results.
    Vincent-Viry M, Deshayes S, Mothe O, Siest G, Galteau MM.
    J Pharm Pharmacol; 1988 Oct 01; 40(10):695-700. PubMed ID: 2907535
    [Abstract] [Full Text] [Related]

  • 3. Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains.
    Küpfer A, Al-Dabbagh SG, Ritchie JC, Idle JR, Smith RL.
    Biochem Pharmacol; 1982 Oct 15; 31(20):3193-9. PubMed ID: 7150348
    [Abstract] [Full Text] [Related]

  • 4. Expansion of the bile acid pool changes the biliary transport characteristics of centrizonal hepatocytes.
    Reichen J, Le M.
    Experientia; 1989 Feb 15; 45(2):135-7. PubMed ID: 2920797
    [Abstract] [Full Text] [Related]

  • 5. Urinary bile acid and bile alcohol excretion does not reflect the genetic polymorphism of debrisoquine hydroxylation.
    Karlaganis G, Küpfer A, Preisig R.
    Br J Clin Pharmacol; 1984 Apr 15; 17(4):470-3. PubMed ID: 6721994
    [Abstract] [Full Text] [Related]

  • 6. Animal modelling of human polymorphic drug oxidation--the metabolism of debrisoquine and phenacetin in rat inbred strains.
    Al-Dabbagh SG, Idle JR, Smith RL.
    J Pharm Pharmacol; 1981 Mar 15; 33(3):161-4. PubMed ID: 6116757
    [Abstract] [Full Text] [Related]

  • 7. Uptake of taurocholate by hepatocytes isolated from developing rats.
    Suchy FJ, Balistreri WF.
    Pediatr Res; 1982 Apr 15; 16(4 Pt 1):282-5. PubMed ID: 7078996
    [Abstract] [Full Text] [Related]

  • 8. In-vivo and in-vitro dextromethorphan metabolism in SD and DA rat. An animal model of the debrisoquine-type polymorphic oxidation in man.
    Zysset T, Zeugin T, Küpfer A.
    Biochem Pharmacol; 1988 Aug 15; 37(16):3155-60. PubMed ID: 3401246
    [Abstract] [Full Text] [Related]

  • 9. Polymorphic ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine.
    Castegnaro M, Bartsch H, Bereziat JC, Arvela P, Michelon J, Broussolle L.
    Xenobiotica; 1989 Feb 15; 19(2):225-30. PubMed ID: 2786290
    [Abstract] [Full Text] [Related]

  • 10. Taurocholate excertion and bile formation in the isolated perfused rat liver. An in vitro-in vivo comparison.
    Paumgartner G, Herz R, Sauter K, Schwarz HP.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Feb 15; 285(2):165-74. PubMed ID: 4281067
    [No Abstract] [Full Text] [Related]

  • 11. Mirex inhibits bile acid secretory function in vivo and in the isolated perfused rat liver.
    Teo S, Vore M.
    Toxicol Appl Pharmacol; 1991 Jun 01; 109(1):161-70. PubMed ID: 1710079
    [Abstract] [Full Text] [Related]

  • 12. Bile acid binding proteins in hepatocellular membranes of newborn and adult rats. Identification of transport proteins with azidobenzamidotauro[14C]cholate ([14C]ABATC).
    Ziegler K, Frimmer M, Müllner S, Fasold H.
    Biochim Biophys Acta; 1989 Apr 14; 980(2):161-8. PubMed ID: 2930783
    [Abstract] [Full Text] [Related]

  • 13. Uptake of bile acids by perfused rat liver.
    Reichen J, Paumgartner G.
    Am J Physiol; 1976 Sep 14; 231(3):734-42. PubMed ID: 788526
    [Abstract] [Full Text] [Related]

  • 14. Lack of relationship between debrisoquine 4-hydroxylation and other cytochrome P-450 dependent reactions in rat and human liver.
    Wolff T, Strecker M.
    Biochem Pharmacol; 1985 Aug 01; 34(15):2593-8. PubMed ID: 4015701
    [Abstract] [Full Text] [Related]

  • 15. Structure-specific inhibition by bile acids of adenosine triphosphate-dependent taurocholate transport in rat canalicular membrane vesicles.
    Nishida T, Che M, Gatmaitan Z, Arias IM.
    Hepatology; 1995 Apr 01; 21(4):1058-62. PubMed ID: 7705779
    [Abstract] [Full Text] [Related]

  • 16. Hepatic clearance and biliary secretory rate maximum of taurocholate in the recirculating and single pass isolated perfused rat liver. Effects of the cholestatic agent, estradiol-17 beta-(beta-D-glucuronide).
    Vore M, Durham S, Yeh S, Ganguly T.
    Biochem Pharmacol; 1991 Feb 01; 41(3):431-7. PubMed ID: 1994901
    [Abstract] [Full Text] [Related]

  • 17. Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes.
    Roy SD, Hawes EM, McKay G, Hubbard JW, Midha KK.
    Can J Physiol Pharmacol; 1985 Jul 01; 63(7):778-81. PubMed ID: 3876145
    [Abstract] [Full Text] [Related]

  • 18. Antipyrine metabolism in female Lewis and Dark Agouti strains of rats, which are extensive and poor metabolizers of debrisoquine, respectively.
    Tanaka E, Kobayashi S, Uchida E, Oguchi K, Yasuhara H.
    Jpn J Pharmacol; 1989 Mar 01; 49(3):433-5. PubMed ID: 2747044
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of ketoconazole-induced elevation of individual serum bile acids in the rat: relationship to the effect of ketoconazole on bile acid uptake by isolated hepatocytes.
    Azer SA, Kukongviriyapan V, Stacey NH.
    J Pharmacol Exp Ther; 1995 Mar 01; 272(3):1231-7. PubMed ID: 7891338
    [Abstract] [Full Text] [Related]

  • 20. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E, Malaveille C, Camus AM, Béréziat JC, Brun G, Castegnaro M, Michelon J, Idle JR, Bartsch H.
    Drug Metab Dispos; 1986 Mar 01; 14(1):118-26. PubMed ID: 2868854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.